McMillan Office, Inc. has revealed its quarterly holdings in a recent SEC filing, marking a significant update for the investment management firm. As of September 30, 2026, the company reported a total investment value of approximately $891.67 million. This disclosure is crucial as it reflects McMillan's ongoing investment strategy and positions within the international equities market.
McMillan Office, Inc., incorporated in Michigan, operates as an investment management firm. The company is primarily focused on managing investments in international equities. The firm has filed several reports with the SEC, including its most recent 13F-HR on November 13, 2026. This filing is part of its ongoing regulatory obligations under the 1934 Act.
The latest filing indicates that McMillan Office holds investments in various international companies, including Accenture PLC, Adient PLC, and AstraZeneca PLC. The firm reported a total of 508 entries in its holdings table, showcasing a diverse portfolio. The value of the investments reflects McMillan's strategic focus on large-cap and mid-cap equities across different sectors.
According to the filing, McMillan's total investment value stands at $891,667,298. This significant amount underscores the firm's active role in the investment management industry. The filing also noted that the investment discretion for these holdings is solely managed by McMillan, indicating a concentrated approach to its investment strategy.
This update may have implications for other firms in the investment management sector, as they may need to reassess their strategies in light of McMillan's disclosures. The competitive landscape in the investment management industry is dynamic, and firms often respond to the movements and strategies of their peers.
Looking ahead, McMillan Office's next steps remain unclear as the filing does not specify any forthcoming actions or additional disclosures. However, the firm is expected to continue monitoring its investments and may provide further updates in future filings.
Read Next
Alpha Tau Medical Reports Positive Interim Results from REGAIN Trial
TOYO Co., Ltd Reports Q3 2026 Results in Latest Filing
NN Inc. to Present at Craig-Hallum Alpha Select Conference
Fresco Gutierrez Diego sells shares of StoneCo Ltd.
Ciena Corp appoints new Chief Product Officer amid changes
Shell plc's Dick Boer Nominated for Philips Supervisory Board










